SHRMF News and Press, Champignon Brands

Braxia Scientific Announces Symbol Change on OTC Markets to "BRAXF" PR Newswire TORONTO , May 20, 2021 /PRNewswire/ - Braxia Scientific Corp. (the "Company"), (CSE: BRAX) (OTC: SHRMF) (FWB: 496), a research driven clinical platform developing and providing n...

/R E P E A T -- Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants/ PR Newswire Over 200 physicians and healthcare providers...

Braxia Scientific Introduces the Braxia Institute, Turning Research to Clinical Action; Over 200 Physicians and Health Care Providers to Attend Braxia's Symposium on Rapid Acting Anti-Depressants PR Newswire Over 200 physicians and healthcare providers from Canada ...

Braxia Scientific Opens First Ketamine Therapy Clinic in Quebec; Enters Joint Venture with Neurotherapy Montreal, A Leading Brain Injury Solutions Clinic for Adults and Children PR Newswire In Quebec , ~20% of the population, or 1 in 5 people, experience mental ill...

Braxia Scientific Introduces "Braxia Health" a Growing Network of Clinics Leading Novel Psychedelic Research and Treatments for Mental Disorders Canada NewsWire Braxia Scientific enters a new chapter as it commences trading under its new ticker "CSE: BRAX" and rebrands...

Braxia Scientific Corp. Comments on Prospective Class Proceeding PR Newswire TORONTO , May 3, 2021 /PRNewswire/ - Braxia Scientific Corp. (the "Company"), (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), (formerly Champignon Brands Inc.) announces that it was served w...

Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities Canada NewsWire TORONTO , May 3, 2021 /CNW/ - Champignon Brands Inc. (the "Company"), (CSE: SHRM) (FWB: ...

Palm Beach, FL – April 28, 2021 – Psychedelic medicine is having a moment. Once dismissed as a “party drug” for its hallucinogenic effects, ketamine is emerging as a novel alternative treatment for depression. For most, psychedelic drugs conjure up images of the ...

New York-based MindMed will begin trading on the Nasdaq today, becoming the second psychedelic company ever to go public on a major American exchange. Shroom drug developer Compass Pathways (CMPS) debuted only six months ago, while another "drug growth platform,"called Atai Life Sciences, fil...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Monday trading may be over, but make sure you are all caught up and ready for the week. To start, what did the stock market do today? And what else should be on your radar? Source: Shutterstock The S&P 500 c...